Brought to you by:
Optimizing acute limb ischemia treatment with a percutaneous-first approach
This advertorial is sponsored by Penumbra. Acute limb ischemia (ALI) management is evolving as new thrombectomy technologies expand the role of endovascular intervention. Jayer Chung, MD, Professor and Medical Director in the Division of Vascular Surgery and Endovascular Therapy at…
Unequal Access, unequal outcomes: Addressing disparities in acute limb ischemia
Although unequal access to care is contributing to persistent disparities in acute limb ischemia (ALI), there is a lot that surgeons can do to improve it. That’s the sentiment of Katharine McGinigle, MD, associate professor of surgery at UNC School…
Acute limb ischemia: Enhancing limb salvage rates with computer-assisted vacuum thrombectomy
This advertorial is sponsored by Penumbra, Inc. Daniel Clair, MD, reflects on the STRIDE study of 30-day outcomes in patients who undergo first-line use of the Indigo Aspiration System and Lightning® (Penumbra) device portfolios for acute limb ischemia (ALI). He…
Tackling difficult acute limb ischemia cases with an endovascular-first approach using Lightning Bolt 7 computer assisted vacuum thrombectomy
This advertorial is sponsored by Penumbra, Inc. Adam Reichard, MD, discusses the use of Lightning Bolt 7® computer-assisted vacuum thrombectomy (CAVTTM) as a first-line option across a wide spectrum of challenging lower extremity acute limb ischemia (ALI) cases, including patients…
Female patients found to be at increased risk from adverse outcomes after an ALI diagnosis
Results from a new study highlighting that female patients are at increased risk of adverse outcomes after acute limb ischemia (ALI) lend weight to the possibility of underdiagnosis and management of vascular disease among women, the authors behind the research…
Pounce Thrombectomy Platform use in acute limb ischemia: Vascular surgeons weigh in
This advertorial is sponsored by Surmodics. Interventions for acute limb ischemia (ALI) represent up to 16% of the case volume for vascular surgeons and cost healthcare systems $26,000–$29,000 per patient in hospitalization costs.¹ While revascularization may be achieved via open or…
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and mortality rates of 88.5% and 12%, respectively. The data were revealed by Thomas Maldonado, MD, professor…
Lightning Bolt 7 ‘stands alone’ in aspiration thrombectomy for acute limb ischemia
This advertorial is sponsored by Penumbra, Inc. “Honestly, there’s nothing even close to it for thrombectomy on the arterial side of things,” according to Martyn Knowles, MD, a vascular and endovascular surgeon at University of North Carolina (UNC) Health Care…
Early data show ‘dramatic improvement’ in amputation-free survival after initiation of novel ‘Limb Alert’ for acute limb ischemia
This advertorial is sponsored by Tampa General Hospital. In cases of acute limb ischemia (ALI), time is of the essence, says Charles J. Bailey, MD—from the moment a patient first reports to the emergency room (ER) through to the time…
Viabahn use in claudicants with long, complex SFA lesions ‘safe and effective’ through five years
Recently published research indicates that stent grafting with the Viabahn endoprosthesis (W L Gore & Associates) of long and complex superficial femoral artery (SFA) lesions in patients with claudication is a safe and effective long-term treatment option. Writing in the Journal of Vascular…